History
  • No items yet
midpage
People v. Davis
57 Cal. 4th 353
Cal.
2013
Read the full case

Background

  • On Dec. 31, 2009, defendant Zachary Davis sold two blue pills to an undercover officer; 19 additional pills were found nearby. Defendant was charged with sale and possession for sale of a controlled substance under Health & Safety Code §§ 11379, 11378, and § 11377.
  • A criminalist tested the pills and identified them as “M.D.M.A. or Ecstasy” in a lab report listing the chemical name 3,4‑methylenedioxymethamphetamine (MDMA); no expert testified about MDMA’s chemical relationship to listed controlled substances or its pharmacological effects.
  • MDMA is not listed in California’s controlled‑substance schedules; the statutory scheme controls listed substances and their analogs (§§ 11054–11058; § 11401 defines analogs by chemical similarity or similar effects).
  • The trial jury was instructed and returned guilty verdicts referencing “Methylenedioxymethamphetamine” and “Ecstasy”; defendant received probation with 90 days jail.
  • The Court of Appeal affirmed after taking judicial notice of scientific treatises to conclude MDMA is chemically related to methamphetamine/amphetamine; the Supreme Court granted review.
  • The Supreme Court reversed: chemical name alone (MDMA) is insufficient to prove the substance is a controlled substance or an analog; the People must present evidence or stipulation that MDMA contains or is an analog of a listed substance or has substantially similar effects.

Issues

Issue Plaintiff's Argument Defendant's Argument Held
Whether MDMA may be proved a controlled substance by its chemical name alone The chemical name 3,4‑methylenedioxymethamphetamine implies it contains methamphetamine/amphetamine; jury may infer from common sense and nomenclature A chemical name not listed in the schedules is insufficient; the People failed to prove MDMA contains or is an analog of a listed drug Chemical name alone is insufficient; prosecution must introduce evidence or stipulation that MDMA contains a listed substance or meets the analog definition
Whether appellate judicial notice of scientific treatises can substitute for proof at trial Treatises show MDMA is a derivative of amphetamine/methamphetamine, supporting the verdict Judicial notice of such facts cannot supply missing proof that was not presented to the jury Appellate judicial notice cannot be used to affirm a conviction when the prosecution failed to prove those facts to the jury
Whether jurors may rely on common knowledge/common sense to infer controlled‑substance status from a chemical name The jury could reasonably infer from the name that MDMA contains methamphetamine/amphetamine The chemistry is not common knowledge; complex chemical nomenclature requires expert proof Facts about complex chemical composition are not within common knowledge; proof is required
Whether the People satisfied the statutory element that the substance be a listed drug or analog The lab report identifying MDMA sufficed to meet the element Identification of MDMA alone does not satisfy the element Identification of MDMA without testimony that it contains or is an analog of a listed substance fails to prove the statutory element

Key Cases Cited

  • People v. Silver, 230 Cal.App.3d 389 (court upheld convictions where prosecution experts testified MDMA was chemically similar to methamphetamine)
  • People v. Becker, 183 Cal.App.4th 1151 (court sustained conviction where expert testimony addressed MDMA’s chemical content and effects)
  • Jackson v. Virginia, 443 U.S. 307 (standard for reviewing sufficiency of the evidence)
  • People v. Peevy, 17 Cal.4th 1184 (appellate courts may not rely on facts not presented to the jury)
  • People v. Medina, 27 Cal.App.3d 473 (if a substance is expressly listed by an accepted name, it is a controlled substance as a matter of law)
Read the full case

Case Details

Case Name: People v. Davis
Court Name: California Supreme Court
Date Published: Jul 25, 2013
Citation: 57 Cal. 4th 353
Docket Number: S198434
Court Abbreviation: Cal.